The association of endothelial nitric oxide synthase G894T polymorphism with C-reactive protein level and metabolic syndrome in a Chinese study group

Metabolism: Clinical and Experimental

Volumn 57, Issue 8, 2008, Pages 1125-1129

  Hsieh, Ming Chia ^a,b   Hsiao, Jeng Yueh ^a   Tien, Kai Jen ^a   Chang, Shun Jen ^c   Lin, Pi Chen ^a   Hsu, Shih Chieh ^a   Liang, Hui Ting ^a   Chen, Hung Chun ^a   Lin, Shiu Ru ^b,d  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

^d FOOYIN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

C-REACTIVE PROTEIN; CHINA; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 47249102900     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.03.018     Document Type: Article

References (54)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA 285 (2001) 2486-2497
2. Raji A., Seely E.W., Arky R.A., and Simonson D.C. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 86 (2001) 5366-5371
3. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
4. Heller D.A., de Faire U., Pedersen N.L., Dahlen G., and McClearn G.E. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 328 (1993) 1150-1156
5. Hong Y., Pedersen N.L., Brismar K., Hall K., and de Faire U. Quantitative genetic analyses of insulin-like frowth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab 81 (1996) 1791-1797
6. Hong Y., Pedersen N.L., Brismar K., and de Faire U. Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am J Hum Genet 60 (1997) 143-152
7. Kissebah A.H., Sonnenberg G.E., Myklebust J., Goldstein M., Broman K., James R.G., et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A 97 (2000) 14478-14483
8. Duplain H., Burcelin R., Sartori C., Cook S., Egli M., Lepori M., et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104 (2001) 342-345
9. Liese A.D., Mayer-Davis E.J., and Haffner S.M. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 20 (1998) 157-172
10. Egashira K., Inou T., Hirooka Y., Yamada A., Maruoka Y., Kai H., et al. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesion. J Clin Invest 91 (1993) 29-37
11. Drexler H., Zeiher A.M., Wollschlager A.M., Meinertz T., Just H., and Bonzel T. Flow dependent coronary artery dilatation in humans. Circulation 80 (1989) 466-474
12. Ferrannini E., Haffner S.M., Mitchell B.D., and Stern M.P. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34 (1991) 416-422
13. Cheal K.L., Abbasia F., Lamendola C., McLaughlin T., Reaven G.M., and Ford E.S. Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 53 (2004) 1195-1200
14. Marsden P.A., Heng H.H., Scherer S.W., Stewart R.J., Hall A.V., Shi X.M., et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268 (1993) 17478-17488
15. Tesauro M., Thompson W.C., Rogliani P., Qi L., Chaudhary P.P., and Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A 97 (2000) 2832-2835
16. Persu A., Stoenoiu M.S., Messiaen T., Davila S., Robino C., El-Khattabi O., et al. Modifier effect of eNOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 11 (2002) 229-241
17. Savvidou M.D., Vallance P.J., Nicolaides K.H., and Hingorani A.D. Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension 38 (2001) 1289-1293
18. Leeson C.P., Hingorani A.D., Mullen M.J., Jeerooburkhan N., Kattenhorn M., Cole T.J., et al. Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res 90 (2002) 153-1158
19. Casas J.P., Bautista L.E., Humphries S.E., and Hingorani A.D. Endothelial nitric oxide synthase genotype and ischemic heart disease. Circulation 109 (2004) 1359-1365
20. Mathews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
21. Cannings C., and Edwards A.W. Expected genotypic frequencies in a small sample: deviation from Hardy-Weinberg equilibrium. Am J Hum Genet 21 (1969) 245-247
22. Kim Y., Suh Y.K., and Choi H. BMI and metabolic disorders in South Korean adults: 1998 Korea National Health and Nutrition Survey. Obes Res 12 (2004) 445-453
23. Thomas G.N., Ho S.Y., Lam K.S., Janus E.D., Hedley A.J., and Lam T.H. Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese. Obes Res 12 (2004) 1805-1813
24. Lee S.H., Kim Y.S., Sunwoo S., and Huh B.Y. A retrospective cohort study on obesity and hypertension risk among Korean adults. J Korean Med Sci 20 (2005) 188-195
25. Femandez M.L., Ruiz R., Gonzalez M.A., Ramirez-Lorca R., Couto C., Ramos A., et al. Association of NOS3 gene with metabolic syndrome in hypertensive patients. Thromb Haemost 92 (2004) 413-418
26. Gonzalez-Sanchez J.L., Martinez-Larrad M.T., Saez M.E., Zabena C., Martinez-Calatrava M.J., and Serrano-Rios M. Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome. Clin Chem 53 (2007) 91-97
27. Ukkola O., Erkkila P.H., Savolainen M.J., and Kesaniemi Y.A. Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med 249 (2001) 451-459
28. Cook S., Hugli O., Egli M., Vollenweider P., Burcelin R., Nicod P., et al. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 133 (2003) 360-363
29. Chen W., Srinivasan S.R., Elkasabany A., Ellsworth D.L., Boerwinkle E., and Berenson G.S. Combined effects of endothelial nitric oxide synthase gene polymorphism (G894T) and insulin resistance status on blood pressure and familial risk of hypertension in young adults: the Bogalusa Heart Study. Am J Hypertens 14 (2001) 1046-1052
30. Jia C.Q., Zhao Z.T., Wang L.H., Hao F.R., Feng Y.Q., Wang S.M., et al. Effects of G894T mutation in the endothelial nitric oxide synthase gene on blood pressure. Zhonghua Liu Xing Bing Xue Za Zhi 24 (2003) 36-39
31. Moe K.T., Lim S.T., Wong P., Chua T., DeSilva D.A., Koh T.H., et al. Association analysis of endothelial nitric oxide synthase gene polymorphism with primary hypertension in a Singapore population. J Hum Hypertens 20 (2006) 956-963
32. Monti L.D., Barlassina C., Citterio L., Galluccio E., Berzuini C., Setola E., et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 52 (2003) 1270-1275
33. Tso Annette W.K., Tan Kathryn C.B., Wat Nelson M.S., Janus E.D., Lam T.H., and Lam Karen S.L. Endothelial nitric oxide synthase G894T (Glu298Asp) polymorphism was predictive of glycemic status in a 5-year prospective study of Chinese subjects with impaired glucose tolerance. Metab Clin Exp 55 (2006) 1155-1158
34. Pieper G.M. Enhanced, unaltered and impaired nitric oxide-mediated endothelium dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia 42 (1999) 204-213
35. Spinas G.A. The dual role of nitric oxide in islet b-cells. News Physiol Sci 14 (1999) 49-54
36. Tesauro M., Thompson W.C., Roglianai P., Qi L., Chaudhary P.P., and Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A 97 (2000) 2832-2835
37. Noiri E., Satoh H., Taguchi J., Brodsky S.V., Nakao A., Ogawa Y., et al. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 40 (2002) 535-540
38. Wang X.L., Sim A.S., Wang M.X., Murrell G.A., Trudinger B., and Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 471 (2000) 45-50
39. Veldman B.A., Spiering W., Doevendans P.A., Vervoort G., Kroon A.A., de Leeuw P.W., et al. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 20 (2002) 2023-2027
40. Ohtoshi K., Yamasaki Y., Gorogawa S., Hayaishi-Okano R., Node K., Matsuhisa M., et al. Association of -786C mutation of endothelial nitric oxide synthase gene with insulin resistance. Diabetologia 45 (2002) 1594-1601
41. Nagassaki S., Metzger I.F., Souza-Costa D.C., Marroni A.S., Uzuelli J.A., and Tanus-Santos J.E. eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population. Thromb Res 115 (2005) 375-379
42. Kuller L.H., Tracy R.P., Shaten J., and Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol 144 (1996) 537-547
43. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
44. Choi E.Y., Park E.H., Cheong Y.S., Rheem I., Park S.G., and Yoo S. Association of C-reactive protein with the metabolic risk factors among young and middle-aged Koreans. Metabolism 55 (2006) 415-421
45. Florez H., Castillo-Florez S., Mendez A., Casanova-Romero P., Larreal-Urdaneta C., Lee D., et al. C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes Res Clin Pract 71 (2006) 92-100
46. Pankow J.S., Folsom A.R., Cushman M., Borecki I.B., Hopkins P.N., Eckfeldt J.H., et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 154 (2001) 681-689
47. Best L.G., North K.E., Tracy R.P., Lee E.T., Howard B.V., Palmieri V., et al. Genetic determination of acute phase reactant levels: the strong heart study. Hum Hered 58 (2004) 112-116
48. Suk H.J., Ridker P.M., Cook N.R., and Zee R.Y. Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 178 (2005) 139-145
49. Smith G.D., Lawlor D.A., Harbord R., Timpson N., Rumley A., Lowe G.D., et al. Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol 25 (2005) 1051-1056
50. Lange L.A., Burdon K., Langefeld C.D., Liu Y., Beck S.R., Rich S.S., et al. Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study. Ann Hum Genet 70 (2006) 717-725
51. Chrysohoou C., Panagiotakos D.B., Pitsavos C., Antoniades C., Skoumas J., Brown M., et al. Evidence for association between endothelial nitric oxide synthase gene polymorphism (G894T) and inflammatory markers: the ATTICA study. Am Heart J 148 (2004) 733-738
52. Kaesemeyer WH Caldwell R.W. Atherosclerosis and nitric oxide production. Circulation 102 (2000) E90
53. McCarty M.F. AMPK activation may suppress hepatic production of C-reactive protein by stimulating nitric oxide synthase. Med Hypotheses 63 (2004) 328-333
54. Fichtlscherer S., Breuer S., Schachinger V., Dimmeler S., and Zeiher A.M. C-reactive protein levels determine systemic nitric oxide bioavailability in patients with coronary artery disease. Eur Heart J 25 (2004) 1412-1418